Mineralys Therapeutics, Inc. MLYS Other operating expenses
Other operating expenses at other companies
Other financials
Where this comes from
Reported directly by Mineralys Therapeutics, Inc. in its filing.
Tagged under the XBRL concept us-gaap:OperatingExpenses.
The official record: Mineralys Therapeutics, Inc.’s 10-Q, filed May 6, 2026, on SEC EDGAR. View the filing →
Ask your AI about Mineralys Therapeutics, Inc.'s other operating expenses.
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude
Questions, answered.
- What is Mineralys Therapeutics, Inc.'s other operating expenses?
- Mineralys Therapeutics, Inc. (MLYS) reported other operating expenses of $45.34M in Q1 2026.
- How has Mineralys Therapeutics, Inc.'s other operating expenses changed year-over-year?
- Mineralys Therapeutics, Inc.'s other operating expenses increased by 2.0% year-over-year, from $44.45M to $45.34M.
- What is the long-term trend for Mineralys Therapeutics, Inc.'s other operating expenses?
- Over 3 years (2022 to 2025), Mineralys Therapeutics, Inc.'s other operating expenses has grown at a 75.7% compound annual growth rate (CAGR), from $31.48M to $170.6M.
- What does other operating expenses mean?
- Residual operating expenses not classified into specific categories, serving as a catch-all for miscellaneous operating costs.